This finding transcends the limitations of traditional exogenous LPS stimulation models, revealing a novel mechanism by which endogenous microbiota metabolic disorders amplify cardiac inflammation by the LPS-TLR4/NF-κB cascade. The gene discussed is TLR4; the disease is metabolic disease.